- Home
- ADXN vs POLA Comparison
ADXN vs POLA Comparison
Compare ADXN & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- POLA
- Stock Information
- Founded
- ADXN 2002
- POLA 1979
- Country
- ADXN Switzerland
- POLA United States
- Employees
- ADXN N/A
- POLA N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- POLA Industrial Machinery/Components
- Sector
- ADXN Health Care
- POLA Miscellaneous
- Exchange
- ADXN Nasdaq
- POLA Nasdaq
- Market Cap
- ADXN 11.3M
- POLA N/A
- IPO Year
- ADXN N/A
- POLA 2016
- Fundamental
- Price
- ADXN $10.30
- POLA $0.47
- Analyst Decision
- ADXN Strong Buy
- POLA
- Analyst Count
- ADXN 1
- POLA 0
- Target Price
- ADXN $30.00
- POLA N/A
- AVG Volume (30 Days)
- ADXN 22.8K
- POLA 452.7K
- Earning Date
- ADXN 11-11-2024
- POLA 11-12-2024
- Dividend Yield
- ADXN N/A
- POLA N/A
- EPS Growth
- ADXN N/A
- POLA N/A
- EPS
- ADXN 0.05
- POLA N/A
- Revenue
- ADXN $960,641.00
- POLA $11,950,000.00
- Revenue This Year
- ADXN N/A
- POLA $6.72
- Revenue Next Year
- ADXN N/A
- POLA N/A
- P/E Ratio
- ADXN $1.75
- POLA N/A
- Revenue Growth
- ADXN N/A
- POLA N/A
- 52 Week Low
- ADXN $5.00
- POLA $0.32
- 52 Week High
- ADXN $27.90
- POLA $0.99
- Technical
- Relative Strength Index (RSI)
- ADXN 54.08
- POLA 49.24
- Support Level
- ADXN $10.04
- POLA $0.44
- Resistance Level
- ADXN $10.81
- POLA $0.54
- Average True Range (ATR)
- ADXN 0.59
- POLA 0.07
- MACD
- ADXN 0.04
- POLA -0.01
- Stochastic Oscillator
- ADXN 70.88
- POLA 20.00
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.